TY  - JOUR
AU  - Monteverde-Fernández, Nicolás
AU  - Cristiani, Federico
AU  - McArthur, Jenniffer
AU  - González-Dambrauskas, Sebastián
PY  - 2019
TI  - Steroids in pediatric acute respiratory distress syndrome
JF  - Annals of Translational Medicine; Vol 7, No 19 (October 15, 2019): Annals of Translational Medicine (Focus on “Pediatric Acute Respiratory Distress Syndrome”)
Y2  - 2019
KW  - 
N2  - Acute respiratory distress syndrome (ARDS) is a complex entity with high potential for harm and healthcare resource utilization. Despite multiple clinical advances in its ventilatory management, ARDS continues to be one of the most challenging disease processes for intensivists. It continues to lack a direct, proven and desperately needed effective therapeutic intervention. Given their biologic rationale, corticosteroids have been widely used by clinicians and considered useful by many in the management of ARDS since its first description. Adult data is abundant, yet contradictory. Controversy remains regarding the routine use of corticosteroids in ARDS. Therefore, widespread evidence-based recommendations for this heterogeneous disease process have not been made. In this article, our aim was to provide a summary of available evidence for the role of steroids in the treatment of ARDS, while giving special focus on pediatric ARDS (PARDS).
UR  - https://atm.amegroups.org/article/view/27939